gefitinib, erlotinib / Apoptosis Cancer Research Results
GB, gefitinib, erlotinib: Click to Expand ⟱
| Features: |
selectively targeting the mutant proteins in malignant cells.
epidermal growth factor receptor (EGFR) inhibitors (lung cancer)
|
Apoptosis, Apoptosis: Click to Expand ⟱
| Source: |
| Type: type of cell death |
Situation in which a cell actively pursues a course toward death upon receiving certain stimuli.
Cancer is one of the scenarios where too little apoptosis occurs, resulting in malignant cells that will not die.
|
Scientific Papers found: Click to Expand⟱
| - |
vitro+vivo, |
NSCLC, |
H1975 |
|
|
|
PDK1↓, eff↑, EGFR↓, Apoptosis↑,
miR-205↑, Let-7↑, Apoptosis↑, miR-200b↑, miR-218↑,
Showing Research Papers: 1 to 2 of 2
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Core Metabolism/Glycolysis(tgid=4) ⓘ
PDK1↓, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↑, 2,
Transcription & Epigenetics(tgid=7) ⓘ
miR-205↑, 1, miR-218↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
Let-7↑, 1,
Migration(tgid=13) ⓘ
miR-200b↑, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
EGFR↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
eff↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
EGFR↓, 1,
Total Targets: 9
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: Apoptosis, Apoptosis
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:7 Target#:14 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page